FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy

Gwynn Ison, Richard Pazdur, Laleh Amiri‐Kordestani et al.|Clinical Cancer Research|2018

Cited by 133